These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 15342400

  • 1. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
    Robertson N, Potter C, Harris AL.
    Cancer Res; 2004 Sep 01; 64(17):6160-5. PubMed ID: 15342400
    [Abstract] [Full Text] [Related]

  • 2. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE, McDonald PC, Lou Y, Serrano I, Chafe SC, Ostlund C, Aparicio S, Winum JY, Supuran CT, Dedhar S.
    Oncogene; 2013 Oct 31; 32(44):5210-9. PubMed ID: 23208505
    [Abstract] [Full Text] [Related]

  • 3. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf dem Keller U, Leung S, Huntsman D, Clarke B, Sutherland BW, Waterhouse D, Bally M, Roskelley C, Overall CM, Minchinton A, Pacchiano F, Carta F, Scozzafava A, Touisni N, Winum JY, Supuran CT, Dedhar S.
    Cancer Res; 2011 May 01; 71(9):3364-76. PubMed ID: 21415165
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.
    Zandberga E, Zayakin P, Ābols A, Pūpola D, Trapencieris P, Linē A.
    Cancer Biol Ther; 2017 Aug 03; 18(8):596-605. PubMed ID: 28665755
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
    Said HM, Hagemann C, Carta F, Katzer A, Polat B, Staab A, Scozzafava A, Anacker J, Vince GH, Flentje M, Supuran CT.
    Bioorg Med Chem; 2013 Jul 01; 21(13):3949-57. PubMed ID: 23706268
    [Abstract] [Full Text] [Related]

  • 11. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
    Dubois L, Peeters SG, van Kuijk SJ, Yaromina A, Lieuwes NG, Saraya R, Biemans R, Rami M, Parvathaneni NK, Vullo D, Vooijs M, Supuran CT, Winum JY, Lambin P.
    Radiother Oncol; 2013 Sep 01; 108(3):523-8. PubMed ID: 23849171
    [Abstract] [Full Text] [Related]

  • 12. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
    Parks SK, Cormerais Y, Durivault J, Pouyssegur J.
    Oncotarget; 2017 Feb 07; 8(6):10225-10237. PubMed ID: 28055960
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition.
    Ledaki I, McIntyre A, Wigfield S, Buffa F, McGowan S, Baban D, Li JL, Harris AL.
    Oncotarget; 2015 Aug 14; 6(23):19413-27. PubMed ID: 26305601
    [Abstract] [Full Text] [Related]

  • 16. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
    Generali D, Fox SB, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield SM, Bruzzi P, Bersiga A, Allevi G, Milani M, Aguggini S, Dogliotti L, Bottini A, Harris AL.
    Endocr Relat Cancer; 2006 Sep 14; 13(3):921-30. PubMed ID: 16954440
    [Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
    Cecchi A, Hulikova A, Pastorek J, Pastoreková S, Scozzafava A, Winum JY, Montero JL, Supuran CT.
    J Med Chem; 2005 Jul 28; 48(15):4834-41. PubMed ID: 16033263
    [Abstract] [Full Text] [Related]

  • 18. The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion.
    Swayampakula M, McDonald PC, Vallejo M, Coyaud E, Chafe SC, Westerback A, Venkateswaran G, Shankar J, Gao G, Laurent EMN, Lou Y, Bennewith KL, Supuran CT, Nabi IR, Raught B, Dedhar S.
    Oncogene; 2017 Nov 09; 36(45):6244-6261. PubMed ID: 28692057
    [Abstract] [Full Text] [Related]

  • 19. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer.
    Kaluz S, Kaluzová M, Stanbridge EJ.
    Cancer Res; 2003 Mar 01; 63(5):917-22. PubMed ID: 12615703
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.